207 related articles for article (PubMed ID: 29797768)
1. Survival times in dogs with presumptive intracranial gliomas treated with oral lomustine: A comparative retrospective study (2008-2017).
Moirano SJ; Dewey CW; Wright KZ; Cohen PW
Vet Comp Oncol; 2018 Dec; 16(4):459-466. PubMed ID: 29797768
[TBL] [Abstract][Full Text] [Related]
2. Comparison between symptomatic treatment and lomustine supplementation in 71 dogs with intracranial, space-occupying lesions.
Van Meervenne S; Verhoeven PS; de Vos J; Gielen IM; Polis I; Van Ham LM
Vet Comp Oncol; 2014 Mar; 12(1):67-77. PubMed ID: 22738696
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of frameless stereotactic radiotherapy for the treatment of presumptive canine intracranial gliomas: A retrospective analysis (2014-2017).
Moirano SJ; Dewey CW; Haney S; Yang J
Vet Comp Oncol; 2020 Dec; 18(4):528-537. PubMed ID: 32011065
[TBL] [Abstract][Full Text] [Related]
4. Tolerability of metronomic administration of lomustine in dogs with cancer.
Tripp CD; Fidel J; Anderson CL; Patrick M; Pratt C; Sellon R; Bryan JN
J Vet Intern Med; 2011; 25(2):278-84. PubMed ID: 21314727
[TBL] [Abstract][Full Text] [Related]
5. Lomustine chemotherapy for the treatment of presumptive haemophagocytic histiocytic sarcoma in Flat-coated Retrievers.
Elliott J
Aust Vet J; 2018 Dec; 96(12):502-507. PubMed ID: 30478839
[TBL] [Abstract][Full Text] [Related]
6. Definitive-intent uniform megavoltage fractioned radiotherapy protocol for presumed canine intracranial gliomas: retrospective analysis of survival and prognostic factors in 38 cases (2013-2019).
Debreuque M; De Fornel P; David I; Delisle F; Ducerveau MN; Devauchelle P; Thibaud JL
BMC Vet Res; 2020 Oct; 16(1):412. PubMed ID: 33129320
[TBL] [Abstract][Full Text] [Related]
7. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE
J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma.
Rassnick KM; Bailey DB; Malone EK; Flory AB; Kiselow MA; Intile JL
J Am Anim Hosp Assoc; 2014; 50(3):167-73. PubMed ID: 24659727
[TBL] [Abstract][Full Text] [Related]
9. Frameless stereotactic radiotherapy alone and combined with temozolomide for presumed canine gliomas.
Dolera M; Malfassi L; Bianchi C; Carrara N; Finesso S; Marcarini S; Mazza G; Pavesi S; Sala M; Urso G
Vet Comp Oncol; 2018 Mar; 16(1):90-101. PubMed ID: 28643878
[TBL] [Abstract][Full Text] [Related]
10. Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.
Burton JH; Venable RO; Vail DM; Williams LE; Clifford CA; Axiak-Bechtel SM; Avery AC; Thamm DH
J Vet Intern Med; 2015; 29(4):1098-104. PubMed ID: 26119008
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral temozolomide in spontaneous canine gliomas: feasibility of a novel therapy using implanted microcylinders.
Hicks J; Platt S; Stewart G; Senneca C; Holmes S; Kent M; Howerth E; Kaplan J; Kaplan E
Vet Med Sci; 2019 Feb; 5(1):5-18. PubMed ID: 30394686
[TBL] [Abstract][Full Text] [Related]
12. Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy.
Mason SL; Finotello R; Blackwood L
Vet Comp Oncol; 2018 Mar; 16(1):E30-E37. PubMed ID: 28621004
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma.
Cannon C; Borgatti A; Henson M; Husbands B
J Small Anim Pract; 2015 Jul; 56(7):425-9. PubMed ID: 25828786
[TBL] [Abstract][Full Text] [Related]
14. Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topic.
Laprais A; Olivry T
BMC Vet Res; 2017 Feb; 13(1):61. PubMed ID: 28222789
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characteristics and prognostic factors for canine multicentric non-indolent T-cell lymphoma: 107 cases.
Purzycka K; Peters LM; Desmas I; Davies O; Chang YM; Lara-Garcia A
Vet Comp Oncol; 2020 Dec; 18(4):656-663. PubMed ID: 32163214
[TBL] [Abstract][Full Text] [Related]
16. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07).
Heading KL; Brockley LK; Bennett PF
Aust Vet J; 2011 Apr; 89(4):109-16. PubMed ID: 21418164
[TBL] [Abstract][Full Text] [Related]
17. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs.
Moore AS; London CA; Wood CA; Williams LE; Cotter SM; L'Heureux DA; Frimberger AE
J Vet Intern Med; 1999; 13(5):395-8. PubMed ID: 10499719
[TBL] [Abstract][Full Text] [Related]
18. Lomustine for the treatment of gastrointestinal mast cell tumour in a dog.
Baldi A; Colloca E; Spugnini EP
J Small Anim Pract; 2006 Aug; 47(8):465-7. PubMed ID: 16911116
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluation of the cost effectiveness of temozolomide for malignant gliomas in British Columbia.
Mabasa VH; Taylor SC
J Oncol Pharm Pract; 2006 Jun; 12(2):105-11. PubMed ID: 16984749
[TBL] [Abstract][Full Text] [Related]
20. CCNU in the treatment of canine epitheliotropic lymphoma.
Williams LE; Rassnick KM; Power HT; Lana SE; Morrison-Collister KE; Hansen K; Johnson JL
J Vet Intern Med; 2006; 20(1):136-43. PubMed ID: 16496933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
